BCL2 and cholangiocarcinoma: In CCA, increased expression levels of Bcl-2 and survivin (anti-apoptotic proteins) are frequently observed and are associated with tumor progression and aggressiveness [8, 9], while the overexpression of Mcl-1 and survivin is associated with drug resistance [10, 11].